1. Home
  2. EZPW vs WVE Comparison

EZPW vs WVE Comparison

Compare EZPW & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EZPW
  • WVE
  • Stock Information
  • Founded
  • EZPW 1989
  • WVE 2012
  • Country
  • EZPW United States
  • WVE Singapore
  • Employees
  • EZPW N/A
  • WVE N/A
  • Industry
  • EZPW Other Specialty Stores
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • EZPW Consumer Discretionary
  • WVE Health Care
  • Exchange
  • EZPW Nasdaq
  • WVE Nasdaq
  • Market Cap
  • EZPW 1.0B
  • WVE 915.6M
  • IPO Year
  • EZPW 1991
  • WVE 2015
  • Fundamental
  • Price
  • EZPW $17.97
  • WVE $6.90
  • Analyst Decision
  • EZPW Strong Buy
  • WVE Strong Buy
  • Analyst Count
  • EZPW 4
  • WVE 14
  • Target Price
  • EZPW $21.00
  • WVE $20.50
  • AVG Volume (30 Days)
  • EZPW 553.0K
  • WVE 3.5M
  • Earning Date
  • EZPW 11-13-2025
  • WVE 11-10-2025
  • Dividend Yield
  • EZPW N/A
  • WVE N/A
  • EPS Growth
  • EZPW 28.89
  • WVE N/A
  • EPS
  • EZPW 1.42
  • WVE N/A
  • Revenue
  • EZPW $1,274,280,000.00
  • WVE $109,230,000.00
  • Revenue This Year
  • EZPW $6.96
  • WVE N/A
  • Revenue Next Year
  • EZPW $10.12
  • WVE $6.24
  • P/E Ratio
  • EZPW $12.61
  • WVE N/A
  • Revenue Growth
  • EZPW 9.70
  • WVE 103.75
  • 52 Week Low
  • EZPW $11.56
  • WVE $5.28
  • 52 Week High
  • EZPW $19.44
  • WVE $16.38
  • Technical
  • Relative Strength Index (RSI)
  • EZPW 49.74
  • WVE 41.30
  • Support Level
  • EZPW $16.50
  • WVE $6.77
  • Resistance Level
  • EZPW $18.48
  • WVE $7.38
  • Average True Range (ATR)
  • EZPW 0.53
  • WVE 0.59
  • MACD
  • EZPW -0.00
  • WVE -0.10
  • Stochastic Oscillator
  • EZPW 68.95
  • WVE 13.93

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: